Myocardial Infarction News and Research

RSS

Heart risks associated with artificial sweeteners

In a recent study published in the British Medical Journal, researchers investigated the relationship between the intake of artificial sweeteners and the risk of all cardiovascular diseases (CVDs), including cardiometabolic disorders.

11 Sep 2022

Study highlights the importance of having a dedicated women-specific heart center

Cardiac conditions in women are underdiagnosed, undertreated, and under-researched compared to men. In an important prospective study in the Canadian Journal of Cardiology, published by Elsevier, investigators report that attending a multidisciplinary dedicated women's heart center can increase the likelihood of an accurate diagnosis and significantly improve clinical and psychological outcomes of women reporting chest pain due to insufficient heart-muscle blood flow (myocardial ischemia) but not diagnosed with obstructive coronary artery disease.

7 Sep 2022

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022 Together with CardioAcademic.

5 Sep 2022

Cooler ambient temperatures in the tropics increase risk of heart attacks

Scientists have long known that temperature changes impact the incidence of heart attacks. However, most of the research done so far has been in temperate climates, where temperatures range widely.

2 Sep 2022

Exploring the muscle symptoms associated with statin therapy

In a new study, investigators explored the influences of statin treatment on muscle symptoms.

31 Aug 2022

Using human tissue models to improve treatment and diagnosis of heart attacks

A heart attack, or myocardial infarction, is one of the leading causes of mortality worldwide, resulting in 18 million deaths per year.

30 Aug 2022

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

A new study reviewed evidence from trials and studies to assess the risks and benefits of using statins to prevent or reduce morbidities or mortalities related to cardiovascular disease (CVD).

29 Aug 2022

$Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction$

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischaemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was associated with a reduction in the risk of death by 49% and in the incidence of hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination.

28 Aug 2022

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

A randomized trial in more than 45,000 men has suggested that cardiovascular screening including cardiac imaging, blood pressure measurement and blood tests, plus treatment if needed, may lower the risk of death, heart attack and stroke in 65 to 69 year-olds.

28 Aug 2022

Study compares the benefits of taking antihypertensive medication in the morning or evening

A pragmatic randomised trial in more than 21,000 patients with high blood pressure followed for over five years has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.

26 Aug 2022

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

A heart check-up is recommended in even apparently healthy people over 65 years of age before intermediate- or high-risk non-cardiac surgery, according to European Society of Cardiology (ESC) Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery published online today in European Heart Journal.

26 Aug 2022

Basic life support training essential for all people to improve survival from cardiac arrest

Basic life support training in schools and communities is essential to improve survival from cardiac arrest, according to European Society of Cardiology (ESC) Guidelines published online today in European Heart Journal.

26 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

Myocardial Infarction News and Research

Heart risks associated with artificial sweeteners

Study highlights the importance of having a dedicated women-specific heart center

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

Cooler ambient temperatures in the tropics increase risk of heart attacks

Exploring the muscle symptoms associated with statin therapy

Using human tissue models to improve treatment and diagnosis of heart attacks

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

Study compares the benefits of taking antihypertensive medication in the morning or evening

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

Basic life support training essential for all people to improve survival from cardiac arrest

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Severe COVID-19 increases risk of future cardiovascular events

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Research shows a correlation between air pollution and heart attacks in non-smokers

What is the association between COVID-19 and thrombotic events?

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News